Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-4-17
|
pubmed:abstractText |
The relationship between cholesterol synthesis and uptake in proliferating lymphocytes has been examined. [14C]Acetate incorporation into lymphocytes cultured under lipoprotein-deficient conditions increased initially in response to mitogen, decreased after 24 h, and increased rapidly between 72 and 96 h. Addition of LDL (10 micrograms/ml) to the culture during the 'trough' period caused [14C]acetate incorporation to return rapidly to baseline, while at peak periods LDL suppression of cholesterol synthesis was minimal. Lymphocytes cultured in the presence of the HMG-CoA reductase inhibitor, mevinolin, exhibited a time-dependent increase in their capacity to incorporate [14C]acetate into cholesterol, evident when mevinolin was removed by washing prior to assay. PHA enhanced 125I-labelled LDL receptor-mediated binding by lymphocytes cultured in lipoprotein-deficient medium over a 4 day period and mevinolin augmented the effect. [3H]Thymidine incorporation into mitogen-stimulated lipoprotein-deficient cultures was inhibited up to 75% by mevinolin (1 mumol/l). LDL (2.5-10 micrograms/ml) substantially reversed this inhibition in 72 h cultures, but only partially overcame inhibition in cells cultured for 96 h. Results suggest that endogenous cholesterol synthesis may be obligatory for lymphocyte proliferation after the initial round of cell division.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetates,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogens
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
1051
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
138-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2310768-Acetates,
pubmed-meshheading:2310768-Cell Division,
pubmed-meshheading:2310768-Cells, Cultured,
pubmed-meshheading:2310768-Cholesterol,
pubmed-meshheading:2310768-Humans,
pubmed-meshheading:2310768-Lipoproteins, LDL,
pubmed-meshheading:2310768-Lovastatin,
pubmed-meshheading:2310768-Lymphocyte Activation,
pubmed-meshheading:2310768-Lymphocytes,
pubmed-meshheading:2310768-Mitogens,
pubmed-meshheading:2310768-Protein Binding,
pubmed-meshheading:2310768-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Cellular cholesterol metabolism in mitogen-stimulated lymphocytes--requirement for de novo synthesis.
|
pubmed:affiliation |
Department of Biochemistry, Royal College of Surgeons in Ireland, Dublin.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|